Sandoz takes over the Japanese business of Aspen Global Incorporated (AGI). The generics subsidiary of Novartis paid up to 400 million euros. AGI was a wholly-owned subsidiary of Aspen Pharmacare Holdings Limited, informed Sandoz on Monday.
The Acquisition was values of shares in Aspen Japan K. K. and the associated assets. Sandoz will make after the completion of the transaction, the first cash settlement in the amount of 300 million euros.
in Addition, have declared that the company is willing to afford then, under certain conditions, deferred payments of a maximum of 100 million euros. The completion of the transaction is subject to the fulfilment of certain suspensive conditions and is expected for the first half of 2020.
With the Acquisition of the Japan business of Aspen could expand Sandoz, the presence in the world’s third-largest generic pharmaceutical marketplace. The Acquisition is complementary to the Portfolio and the Pipeline of generic and biosimilar products for hospitals, with its own sales, Marketing and medical organization, it was called more.
The Portfolio of Aspen consists of patent-free drugs, with a focus on anesthesia and the special brands.
(red/sda)
Created: 11.11.2019, 09:11 PM
